| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Kalnin Christopher P | Chief Executive Officer, Director | 1200 17TH STREET, SUITE 2100, DENVER | /s/ Kathleen Lenox, attorney-in-fact | 02 Jan 2026 | 0001953932 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | BKV | Common Stock | Award | $21,238 | +1,125 | +0.09% | $18.88 | 1,249,705 | 02 Jan 2026 | Direct | F1, F2 |
| holding | BKV | Common Stock | 875,754 | 02 Jan 2026 | By Spouse |
| Id | Content |
|---|---|
| F1 | The shares were acquired under the BKV Corporation Employee Stock Purchase Plan ("ESPP") in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c). The reporting person is voluntarily reporting this transaction. |
| F2 | In accordance with the ESPP, these shares were purchased at a price equal to 85% of the lesser of (i) closing price of the Issuer's common stock on the first trading day of the offering period, July 1, 2025, or (ii) closing price of the Issuer's common stock on the last trading day of the offering period, December 31, 2025. |